The effect of cardiovascular drugs on erectile function: Literature review
Open Access
- 25 June 2026
- journal article
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 7,p. 238-246
Abstract
Erectile dysfunction (ED) is a common problem among the male population over 40 years old. Arterial hypertension, dyslipidemia and other cardiovascular diseases (CVDs), as well as some of the medications which are used to treat CVDs can affect erectile function (EF). This article discusses current data about cardiovascular drugs effect on EF and analyzes scientific literature from the following scientific databases: PubMed, ScienceDirect, and eLIBRARY.RU. Angiotensin II receptor blockers have a positive effect on EF. ED, as one of the possible side effects, can be observed during treatment by most beta-blockers (with the exception of nebivolol), diuretics, and non-selective mineralocorticoid receptor antagonists. There is no convincing evidence of a negative effect of angiotensin-converting enzyme inhibitors, calcium channel blockers, selective mineralocorticoid receptor antagonists, and metoprolol on EF. The data of the effect of statin therapy on EF is contradictory. There is a limited number of studies about interaction between angiotensin receptors, neprilysin inhibitors and EF. In many studies subjective methods of EF assessment are used. CVDs and ED have common risk factors and pathogenic mechanisms. Large-scale biobank studies using Mendelian randomization show that ED is more strongly associated with the presence of CVDs rather than with the medications. To clarify CVD drugs effects on EF it is necessary to conduct studies with objective assessment of EF using nighttime penile tumescence monitoring. Knowledge of the characteristics of CVD drugs allows doctors to provide patient with an individualized therapy without adverse events, and ensures a high level of patient adherence to treatment.Keywords
This publication has 82 references indexed in Scilit:
- Anti-hypertensive medications and erectile dysfunction: focus on β-blockersEndocrine, 2024
- Effects of Major Antihypertensive Drug Classes on Erectile Function: a Network Meta-analysisCardiovascular Drugs and Therapy, 2021
- Effects of isolated or combined exposure to sibutramine and rosuvastatin on reproductive parameters of adult male ratsJournal of Applied Toxicology, 2020
- Safety of Nifedipine GITS in Stable Angina: The ACTION TrialCardiovascular Drugs and Therapy, 2006
- Pharmacokinetics and Pharmacodynamics of Mineralocorticoid Blocking Agents and their Effects on Potassium HomeostasisHeart Failure Reviews, 2005
- Lipid‐Altering Efficacy and Safety of Simvastatin 80 mg/Day: Long‐Term Experience in a Large Group of Patients with HypercholesterolemiaClinical Cardiology, 2000
- Long-term therapy with high-dose simvastatin does not affect adrenocortical and gonadal hormones in hypercholesterolemic patientsMetabolism, 1992
- The Impact of Diuretic Therapy on Reported Sexual FunctionArchives of internal medicine (1960), 1991
- Beta-blocker effects on sexual function in normal malesArchives of Sexual Behavior, 1988
- Increased Antidepressant Use in Patients Prescribed β-BlockersJAMA, 1986